ArticleCurrent cancer drug targets2024

Dauricine Inhibits Non-small Cell Lung Cancer Development by Regulating PTEN/AKT/mTOR and Ras/MEK1/2/ERK1/2 Pathways in a FLT4-dependent Manner.

Jinna Liang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.